Serum adalimumab levels predict successful remission and safe de-intensification in inflammatory bowel disease patients in clinical practice
Fecha de publicación:
Autores de IIS La Fe
Grupos
Abstract
Abstract no disponible
Filiaciones
Filiaciones no disponibles
Campos de Estudio
Cita
Aguas,M,Boso,V,Navarro,B,Marques,MR,Bastida,G,Beltran,B,Iborra,M et al. Serum adalimumab levels predict successful remission and safe de-intensification in inflammatory bowel disease patients in clinical practice. GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND:OXFORD UNIV PRESS. 2017 p.p. 263-263.
Portal de investigación